Table 2.
Central tendency, variability of the EORTC QLQ-BR23 scale
| N | Median | Mean | Standard deviation | Floor effect a (%) | Ceiling effect b (%) | |
|---|---|---|---|---|---|---|
|
Body image |
105 |
83.33 |
77.54 |
25.82 |
0.0 |
39.0 |
|
Sexual functioning |
66 |
66.66 |
61.11 |
29.83 |
3.8 |
13.3 |
|
Sexual enjoyment |
53 |
66.67 |
58.49 |
29.17 |
5.7 |
8.6 |
|
Future perspective |
105 |
66.67 |
46.98 |
41.27 |
39.0 |
24.8 |
|
Systemic therapy side effects |
105 |
57.14 |
59.86 |
22.98 |
1.0 |
2.9 |
|
Breast symptoms |
105 |
83.33 |
77.86 |
19.94 |
0.0 |
25.7 |
|
Arm symptoms |
105 |
77.78 |
0.00 |
26.64 |
1.9 |
22.9 |
| Upset by hair loss | 50 | 68.94 | 34.00 | 41.23 | 25.7 | 9.5 |
aPercentage of the lowest modality.
bPercentage of the highest modality.